Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4944)
All Articles published online
|
Publishing Process of This Article
|
May 27, 2022 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cianci N, Subhani M, Hill T, Khanna A, Zheng D, Sheth A, Crooks C, Aithal GP. Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis. World J Hepatol 2022; 14(5): 1025-1037 [PMID: 35721296 DOI: 10.4254/wjh.v14.i5.1025] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i5/1025.htm |
| Number | Citing Articles |
| 1 |
Chung‐Feng Huang, Po‐Cheng Liang, Chih‐Wen Wang, Tyng‐Yuan Jang, Po‐Yao Hsu, Pei‐Chien Tsai, Yu‐Ju Wei, Ming‐Lun Yeh, Ming‐Yen Hsieh, Yi‐Hung Lin, Chao‐Kuan Huang, Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu. Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis. The Kaohsiung Journal of Medical Sciences 2024; 40(4): 374 doi: 10.1002/kjm2.12804
|
| 2 |
Mirko Zoncapè, Antonio Liguori, Emmanuel A. Tsochatzis. Non-invasive testing and risk-stratification in patients with MASLD. European Journal of Internal Medicine 2024; 122: 11 doi: 10.1016/j.ejim.2024.01.013
|
| 3 |
Arun J. Sanyal, Laurent Castera, Vincent Wai-Sun Wong. Noninvasive Assessment of Liver Fibrosis in NAFLD. Clinical Gastroenterology and Hepatology 2023; 21(8): 2026 doi: 10.1016/j.cgh.2023.03.042
|
| 4 |
Abdulrahman Ismaiel, Oana Sabina Ciobanu, Mohamed Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Liliana David, Dilara Ensar, Nahlah Al Srouji, Dan L. Dumitrascu. Atherogenic Index of Plasma in Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Biomedicines 2022; 10(9): 2101 doi: 10.3390/biomedicines10092101
|
| 5 |
Barak Mizrahi, Tamar Sudry, Natalie Flaks-Manov, Yoav Yehezkelli, Nir Kalkstein, Pinchas Akiva, Anat Ekka-Zohar, Shirley Shapiro Ben David, Uri Lerner, Maytal Bivas-Benita, Shira Greenfeld. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 2023; : e072529 doi: 10.1136/bmj-2022-072529
|
| 6 |
Eveline Gart, Wim van Duyvenvoorde, Jessica M. Snabel, Christa de Ruiter, Joline Attema, Martien P.M. Caspers, Serene Lek, Bertie Joan van Heuven, Arjen G.C.L. Speksnijder, Martin Giera, Aswin Menke, Kanita Salic, Kendra K. Bence, Gregory J. Tesz, Jaap Keijer, Robert Kleemann, Martine C. Morrison. Translational characterization of the temporal dynamics of metabolic dysfunctions in liver, adipose tissue and the gut during diet-induced NASH development in Ldlr−/−.Leiden mice. Heliyon 2023; 9(3): e13985 doi: 10.1016/j.heliyon.2023.e13985
|
| 7 |
Amedeo Lonardo, Stefano Ballestri, Gyorgy Baffy, Ralf Weiskirchen. Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease. Metabolism and Target Organ Damage 2024; 4(4) doi: 10.20517/mtod.2024.42
|
| 8 |
Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne. Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future. Clinical and Molecular Hepatology 2023; 29(Suppl): S157 doi: 10.3350/cmh.2022.0348
|